biologics

Wilmington, Delaware, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Global Biologics Contract Manufacturing Market value is estimated at US$ 15.5 billion in 2023 and is expected to grow at a significant CAGR of over 9.5% over the forecast period of…

Un partenariat basé sur un candidat vaccin offrant une protection élevée identifié par la plateforme EDEN™ d'EvaxionDans le cadre de cette collaboration, les partenaires auront accès à la technologie de l'ARN messager (ARNm) du centre de…

Wilmington, Delaware, United States, July 31, 2023 (GLOBE NEWSWIRE) -- The global atopic dermatitis drugs market stood at US$ 6.0 billion in 2021, and the global market is projected to reach US$ 29.4 billion by 2031. The global industry…

Acquisition to Enhance Xtant’s Growing Spinal Fusion Devices Portfolio BELGRADE, Mont., July 28, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical…

BOSTON and SHANGHAI, China and LAUSANNE, Switzerland, July 24, 2023 (GLOBE NEWSWIRE) -- Overland ADCT BioPharma, a joint venture of Overland Pharmaceuticals (CY) Inc. and ADC Therapeutics SA (NYSE: ADCT), today announced that the China…

Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the…

Alvotech (NASDAQ: ALVO) og Teva Pharmaceuticals, bandarískt dótturfélag Teva Pharmaceutical Industries Ltd. (NYSE og TASE: TEVA) tilkynntu í dag um aukið samstarf á sviði þróunar, framleiðslu og markaðssetningar á líftæknilyfjahliðstæðum.…

New York, USA, July 20, 2023 (GLOBE NEWSWIRE) -- Spine Biologics Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Spine Biologics Market Information By Product, By Surgery Type, By End…

SAN FRANCISCO, July 19, 2023 (GLOBE NEWSWIRE) -- Culture Biosciences is excited to welcome Eliana Clark, PhD, Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc., to the company’s Advisory Board. The group…

First MSC-derived Extracellular Vesicles interventional study approved by the European Medicines Agency. Liège, Belgium 17 July 2023 – EXO Biologics SA, a Belgian biotech company committed to developing biopharmaceuticals using…